Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant gender » significant concern (Expand Search), significant burden (Expand Search)
significant level » significance level (Expand Search), significance levels (Expand Search), significant loss (Expand Search)
Showing 1,441 - 1,460 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant level) OR (significant gender)) decrease ))*', query time: 0.54s Refine Results
  1. 1441
    Flowchart of participants in this study.

    Flowchart of participants in this study. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1442
    Nonlinear relationship between UACR and cognitive impairment.

    Nonlinear relationship between UACR and cognitive impairment. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1443
    Threshold effect analysis of UACR and cognitive impairment.

    Threshold effect analysis of UACR and cognitive impairment. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1444
    Analyzing the relationship between UACR (<30) and cognitive scores and impairment.

    Analyzing the relationship between UACR (<30) and cognitive scores and impairment. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1445
    Analyzing the relationship between UACR and cognitive scores and impairment.

    Analyzing the relationship between UACR and cognitive scores and impairment. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1446
    Baseline characteristics of participants (N = 2385) by UACR.

    Baseline characteristics of participants (N = 2385) by UACR. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1447
    ROC curve according to their D-dimer values in patients with PFS ≥ 1 year and those with PFS < 1 year. p < 0.001 (95% CI: 4-21).

    ROC curve according to their D-dimer values in patients with PFS ≥ 1 year and those with PFS < 1 year. p < 0.001 (95% CI: 4-21). by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1448
    Kaplan Meier curves of OS and PFS according to RT and/or CRT response.

    Kaplan Meier curves of OS and PFS according to RT and/or CRT response. by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1449
    Univariate and multivariable analyses for progression free survival.

    Univariate and multivariable analyses for progression free survival. by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1450
    Kaplan Meier curves of OS and PFS according to different pre-RT different D-dimer values.

    Kaplan Meier curves of OS and PFS according to different pre-RT different D-dimer values. by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1451
    Univariate and multivariable analyses for OS.

    Univariate and multivariable analyses for OS. by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1452
    Characteristics of LC patients.

    Characteristics of LC patients. by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1453
    Decision curve analysis according to t D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year.

    Decision curve analysis according to t D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1454
    ROC curve according to their D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. p < 0.001 (95% CI: 6-24).

    ROC curve according to their D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. p < 0.001 (95% CI: 6-24). by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1455
    Flowchart of this study.

    Flowchart of this study. by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1456
    RT characteristics and D-dimer, OS and PFS of patients.

    RT characteristics and D-dimer, OS and PFS of patients. by Huriye Senay Kiziltan (22298378)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1457
    Gene expression levels of <i>CB1R</i>, <i>CB2R</i>, and <i>MAGL</i> in KA-injected mice treated with compound 4f.

    Gene expression levels of <i>CB1R</i>, <i>CB2R</i>, and <i>MAGL</i> in KA-injected mice treated with compound 4f. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1458
    Resistant Starch Nanoparticles Induce Colitis through Lysosomal Exocytosis in Mice

    Resistant Starch Nanoparticles Induce Colitis through Lysosomal Exocytosis in Mice by Chenglu Peng (19935965)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 1459
    Oviduct Glycoprotein 1 (OVGP1) Diagnoses Polycystic Ovary Syndrome (PCOS) Based on Machine Learning Algorithms

    Oviduct Glycoprotein 1 (OVGP1) Diagnoses Polycystic Ovary Syndrome (PCOS) Based on Machine Learning Algorithms by Fengjuan Wang (768949)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1460
    (A) Beta-diversity non-metric multidimensional scaling (NMDS) analysis at genus level, and (B) LEfSe for bacterial species biomarkers representing control vs. stroke groups.

    (A) Beta-diversity non-metric multidimensional scaling (NMDS) analysis at genus level, and (B) LEfSe for bacterial species biomarkers representing control vs. stroke groups. by Duangnapa Roongpiboonsopit (12829198)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: